Q4 2017 13F Holders as of 31 Dec 2017
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
42,998,448
-
Total 13F shares
-
41,893,801
-
Share change
-
-1,916,427
-
Total reported value
-
$1,912,243,195
-
Put/Call ratio
-
56%
-
Price per share
-
$45.65
-
Number of holders
-
180
-
Value change
-
-$62,679,837
-
Number of buys
-
100
-
Number of sells
-
80
Institutional Holders of Pacira BioSciences, Inc. - Common Stock, par value $0.001 per share (PCRX) as of Q4 2017
As of 31 Dec 2017,
Pacira BioSciences, Inc. - Common Stock, par value $0.001 per share (PCRX) was held by
180 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
41,893,801 shares.
The largest 10 holders included
BlackRock Inc., Vanguard Group Inc, HealthCor Management, L.P., PRICE T ROWE ASSOCIATES INC /MD/, Consonance Capital Management LP, MACQUARIE GROUP LTD, WESTFIELD CAPITAL MANAGEMENT CO LP, DARUMA CAPITAL MANAGEMENT LLC, PointState Capital LP, and Rock Springs Capital Management LP.
This page lists
180
institutional shareholders reporting positions in this security
for the Q4 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.